146 related articles for article (PubMed ID: 8927664)
1. The relationship of plasma imipramine and N-desmethylimipramine to response in panic disorder.
Mavissakalian MR; Perel JM
Psychopharmacol Bull; 1996; 32(1):143-7. PubMed ID: 8927664
[TBL] [Abstract][Full Text] [Related]
2. The relationship of plasma imipramine and N-desmethylimipramine to improvement in agoraphobia.
Mavissakalian M; Perel JM; Michelson L
J Clin Psychopharmacol; 1984 Feb; 4(1):36-40. PubMed ID: 6693582
[TBL] [Abstract][Full Text] [Related]
3. Dose-response characterization of the antipanic effects of imipramine.
Mavissakalian MR; Perel JM
Psychopharmacol Bull; 1994; 30(2):171-4. PubMed ID: 7831451
[TBL] [Abstract][Full Text] [Related]
4. Imipramine treatment of panic disorder with agoraphobia: dose ranging and plasma level-response relationships.
Mavissakalian MR; Perel JM
Am J Psychiatry; 1995 May; 152(5):673-82. PubMed ID: 7726306
[TBL] [Abstract][Full Text] [Related]
5. [Clinical usefulness of monitoring serum levels of imipramine and desipramine in patients treated for endogenous depression].
Szymura-Oleksiak J; Wasieczko A
Psychiatr Pol; 1991; 25(1):54-60. PubMed ID: 1780375
[TBL] [Abstract][Full Text] [Related]
6. Patterns of plasma imipramine-desipramine concentrations in patients receiving concomitant fluphenazine decanoate.
Siris SG; Adan F; Lee A; Cooper TB; Mandeli J; Casey E
J Clin Psychiatry; 1988 Feb; 49(2):64-5. PubMed ID: 3338977
[TBL] [Abstract][Full Text] [Related]
7. Tricyclic antidepressant-induced seizures and plasma drug concentration.
Preskorn SH; Fast GA
J Clin Psychiatry; 1992 May; 53(5):160-2. PubMed ID: 1592842
[TBL] [Abstract][Full Text] [Related]
8. Depression in children: relationship between plasma imipramine levels and response.
Preskorn SH; Weller EB; Weller RA
J Clin Psychiatry; 1982 Nov; 43(11):450-3. PubMed ID: 7174621
[TBL] [Abstract][Full Text] [Related]
9. Excessive plasma concentration of tricyclic antidepressants resulting from usual doses: a report of six cases.
Devane CL; Wolin RE; Rovere RA; Panahon NC; Sutfin TA; Jusko WJ
J Clin Psychiatry; 1981 Apr; 42(4):143-7. PubMed ID: 7204359
[TBL] [Abstract][Full Text] [Related]
10. Plasma levels of tricyclic antidepressants in panic disorder.
Sweeney DR; Gold MS; Pottash AL; Martin D
Int J Psychiatry Med; 1983-1984; 13(2):93-6. PubMed ID: 6642878
[TBL] [Abstract][Full Text] [Related]
11. Imipramine and desipramine plasma levels: relationship to dosage schedule and sampling time.
Ziegler VE; Biggs JT; Rosen SH; Meyer DA; Preskorn SH
J Clin Psychiatry; 1978 Aug; 39(8):660-3. PubMed ID: 681303
[TBL] [Abstract][Full Text] [Related]
12. Tricyclic antidepressant concentrations in plasma: an estimate of their sensitivity and specificity as a predictor of response.
Perry PJ; Zeilmann C; Arndt S
J Clin Psychopharmacol; 1994 Aug; 14(4):230-40. PubMed ID: 7962678
[TBL] [Abstract][Full Text] [Related]
13. Fluvoxamine-induced alterations in plasma concentrations of imipramine and desipramine in depressed patients.
Spina E; Pollicino AM; Avenoso A; Campo GM; Caputi AP
Int J Clin Pharmacol Res; 1993; 13(3):167-71. PubMed ID: 8225700
[TBL] [Abstract][Full Text] [Related]
14. Prediction of steady-state imipramine and desmethylimipramine plasma concentrations from single-dose data.
Brunswick DJ; Amsterdam JD; Mendels J; Stern SL
Clin Pharmacol Ther; 1979 May; 25(5 Pt 1):605-10. PubMed ID: 436362
[TBL] [Abstract][Full Text] [Related]
15. The relationship of plasma imipramine and N-desmethylimipramine to improvement in agoraphobia.
Mavissakalian M; Perel J; Michelson L
Psychopharmacol Bull; 1984; 20(1):123-5. PubMed ID: 6718637
[No Abstract] [Full Text] [Related]
16. Imipramine blood levels and clinical outcome.
Rigal JG; Albin HC; Duchier AR; D'Aulnay JM; Fenelon JH; Vincon GA; Demotes-Mainard FM
J Clin Psychopharmacol; 1987 Aug; 7(4):222-9. PubMed ID: 3624505
[TBL] [Abstract][Full Text] [Related]
17. Imipramine dose-response relationship in panic disorder with agoraphobia. Preliminary findings.
Mavissakalian MR; Perel JM
Arch Gen Psychiatry; 1989 Feb; 46(2):127-31. PubMed ID: 2643933
[TBL] [Abstract][Full Text] [Related]
18. An explanatory statistical model for plasma levels of imipramine and desmethylimipramine during long-term therapy.
Roberts CD; Roberts EN
Br J Psychiatry; 1973 Jun; 122(571):736-7. PubMed ID: 4716078
[No Abstract] [Full Text] [Related]
19. 2nd year maintenance and discontinuation of imipramine in panic disorder with agoraphobia.
Mavissakalian MR; Perel JM
Ann Clin Psychiatry; 2001 Jun; 13(2):63-7. PubMed ID: 11534926
[TBL] [Abstract][Full Text] [Related]
20. Prediction of steady-state plasma levels of doxepin and imipramine from single dose levels in depressed outpatients.
Hrdina PD; Bakish D; Swenson S; Lapierre YD
J Psychiatry Neurosci; 1991 Mar; 16(1):25-9. PubMed ID: 2049367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
